Tomomi Kawakita
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.
Journal: Molecular therapy. Nucleic acids
Published: May 10, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.
Journal: Journal of virology
Published: April 15, 2025
ARNAX, but not conventional adjuvants, alum and squalene, induces antigen-specific CD8+ T cell proliferation in vaccination with influenza split vaccine.
Journal: International immunopharmacology
Published: February 17, 2025
Optimization of the preparation method of inactivated intact virus particle vaccine for COVID-19.
Journal: Vaccine
Published: December 19, 2024
A Case of Infection with Leptospires from Three Different Serovars During a Flood in the Philippines.
Journal: The American journal of tropical medicine and hygiene
Published: June 18, 2024
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
Journal: Journal of virology
Published: February 07, 2024
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Journal: Scientific reports
Published: November 02, 2023
Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination.
Journal: Cells
Published: April 26, 2023
Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.
Journal: Vaccines
Published: April 12, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026